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Abstract
Burkholderia pseudomallei is the causative agent of melioidosis and a potential bioterrorism
agent. In the development of medical countermeasures against B. pseudomallei infection,
the US Food and Drug Administration (FDA) animal Rule recommends using well-charac-
terized strains in animal challenge studies. In this study, whole genome sequence data
were generated for 6 B. pseudomallei isolates previously identified as candidates for animal
challenge studies; an additional 5 isolates were sequenced that were associated with
human inhalational melioidosis. A core genome single nucleotide polymorphism (SNP) phy-
logeny inferred from a concatenated SNP alignment from the 11 isolates sequenced in this
study and a diverse global collection of isolates demonstrated the diversity of the proposed
Animal Rule isolates. To understand the genomic composition of each isolate, a large-scale
blast score ratio (LS-BSR) analysis was performed on the entire pan-genome; this demon-
strated the variable composition of genes across the panel and also helped to identify
genes unique to individual isolates. In addition, a set of ~550 genes associated with patho-
genesis in B. pseudomallei were screened against the 11 sequenced genomes with LS-
BSR. Differential gene distribution for 54 virulence-associated genes was observed be-
tween genomes and three of these genes were correlated with differential virulence ob-
served in animal challenge studies using BALB/c mice. Differentially conserved genes and
SNPs associated with disease severity were identified and could be the basis for future
studies investigating the pathogenesis of B. pseudomallei. Overall, the genetic
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characterization of the 11 proposed Animal Rule isolates provides context for future studies
involving B. pseudomallei pathogenesis, differential virulence, and efficacy to therapeutics.
Introduction
Burkholderia pseudomallei is a pathogen endemic to Southeast Asia and Northern Australia
but is increasingly found in other parts of the world including India, South America, and Af-
rica, where it is naturally found in soil and water [1]. The bacterium is the causative agent of
melioidosis [2–5], a potentially fatal disease in humans. B. pseudomallei is also considered to be
a Tier 1 biothreat agent due to its ease of attainment, ability to cause lethal disease, intrinsic an-
tibiotic resistance [6], and lack of a melioidosis vaccine [7]. The development of appropriate
medical countermeasures against melioidosis has been hampered by access to human patients
for clinical trials with compounds that are not currently approved for the treatment of melioi-
dosis. To address this concern, the US Food and Drug Administration (FDA) has instituted the
“Animal Rule” 21 CFR that calls for well-characterized strains to be used in animal challenge
studies [8], including BALB/c mice, which have shown to represent acute human melioidosis
[9]. Based on several selection criteria, a recent study selected a panel of six B. pseudomallei
strains that would be appropriate for challenge studies under the FDA Animal Rule [7].
In the current study, we used whole-genome sequencing (WGS) to genetically characterize
a panel of B. pseudomallei strains to be used as challenge material in therapeutic efficacy studies
under the Animal Rule. In addition, we sequenced 5 B. pseudomallei strains associated with in-
halational disease for evaluation as potential challenge strains. The purpose of WGS on these
isolates was to (1) characterize the genomic background in each isolate; (2) identify the phylo-
genetic diversity of panel isolates in the context of a global set of genomes and; (3) identify the
distribution of characterized virulence factors for correlation with virulence data obtained in
animal challenge studies.
Methods
Strain selection
Eleven diverse isolates were selected for sequencing (Table 1). Six of these isolates were previ-
ously selected as part of a proposed B. pseudomallei strain panel, based on several selection cri-
teria [7]. For five of these isolates, there are finished genome assemblies available in public
databases [10]; these genomes were sequenced to identify any mutations compared to the pub-
lished genomes. The genome for an additional isolate, NCTC 13392, has previously been pub-
lished [11]. An additional 5 isolates were selected based on recent isolation and suspected
inhalational disease and were associated with acute pneumonia sepsis.
Animal challenge studies
285 BALB/c mice (100% female) were purchased from Charles River Laboratories and were
randomly selected and placed into challenge groups (n = 7) based on different isolates and dos-
ing. Mice here housed in Innovive IVC mouse racks using disposable caging (7 mice per cage).
Sedated mice were challenged by intranasal inoculation (15 μl per nare) of target doses diluted
in Dulbecco’s Phosphate-Buffered Saline (PBS); mice were anesthetized intraperitoneally with
ketamine (50–120 mg/kg) and xylazine (5–10 mg/kg). Prior to challenge, cultures were grown
for 22 hours shaking at 37°C at 250xRPM; no mice were mock-treated in this study. The
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culture was then centrifuged and re-suspended in PBS containing 0.01% gelatin. The concen-
tration of each challenge dilution was determined by spread plate enumeration.
Following challenge, mice were monitored every 8 hours between days 1 and 7, then twice
daily between days 8 and 21; sample HBPUB10303a was only challenged for 14 days due to un-
foreseen delays in starting the experiment. Observations were made for clinical signs of illness,
including respiratory distress, loss of appetite and activity, and seizures; any animal judged to
be moribund by a trained animal technician was humanely euthanized. All study survivors
were humanely euthanized with CO2 inhalation on Study Day 21. Kaplan-Meier survival
curves were created using the ‘survival’ package in R [12]. Animal challenge studies were con-
ducted at the Battelle Biomedical Research Center (BBRC). All animal work was approved by
Battelle’s IACUC prior to study initiation.
DNA extraction, library creation, sequencing
DNA library constructions were performed using the KAPA Library Preparation Kits with
Standard PCR Library Amplification/Illumina series (KAPA biosystems, Boston MA, code
KK8201). Quality and quantity of genomic DNA were evaluated by agarose gel analysis. One
to two micrograms of DNA per sample were fragmented using a SonicMan (Matrical) with fol-
lowing parameters: 75.0 seconds pre chill, 16 cycles, 10.0 sec sonication, 100% power, 75.0 sec
lid chill, 10.0 sec plate chill, and 75.0 sec post chill. The fragmented DNA was purified using
QIAGEN QIAquick PCR purification columns (QIAGEN, cat. no. 28104) and eluted into
42.5 μl of Elution Buffer. The adapter ligation used 1.5 μl of the 40 μM adapter oligo mix [13].
Only one post-ligation bead cleanup was done. All purification steps were done with the 1.8x
SPRI bead protocol in the KAPA protocol. Size selection of fragments was gel based; 30 μl of
clean ligated material was run onto a 2% agarose gel. Several gel slices, corresponding to differ-
ent average DNA fragment sizes (300, 600, and 1000bp fragments) were extracted from the gel
and purified with a QIAGEN Gel Extraction kit (QIAGEN, cat. no. 28704) and eluted in 30 μl
of Elution Buffer. Due to the high GC content of the samples, the PCR was optimized to im-
prove yield and genomic coverage. Two microliters of DNA, 2 μl of 10 μM of both primers,
25 μl of NEBNext High-Fidelity 2X PCRMaster Mix (New England Biolabs, Ipswich, MA, cat.
no. M0541S), and 22 μl of 5 M Betaine (Sigma-Aldrich, St. Louis, MO, cat. no. B0300-1VL)
were combined. The following PCR parameters were used: initial denaturation of 2 min at
Table 1. Details of isolates sequenced in current study.
Isolate Isolation source Isolation country Isolation Year Passages SRA Genbank Accession BEI accession
1106a* liver abscess Thailand 1993 10 SRX263957 N/A NR-44208
K96243* blood Thailand 1996 22 SRR797065 N/A NR-44206
MSHR305* brain Australia 1994 10 SRX263963 N/A NR-44225
MSHR668* blood Australia 1995 11 SRX259746 N/A NR-44224
406e* toe swab Thailand 1988 10 SRX256398 AQTK00000000 NR-44207
NCTC 13392* unknown Thailand 1996 unknown SRX245558 AOUG00000000 N/A
1026b* blood Thailand 1993 9 SRX259661 N/A NR-9910
MSHR5855 sputum Australia 2011 7 SRX526461 JMMV00000000 NR-45120
MSHR5858 sputum Australia 2011 2 SRX264496 AVAK00000000 NR-45120
HBPUB10134a sputum Thailand 2010 10 SRR796658 AVAL00000000 NR-44220
HBPUB10303a sputum Thailand 2011 10 SRX254948 AVAM00000000 NR-44221
*genome has been sequenced previously
doi:10.1371/journal.pone.0121052.t001
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98°C, 12 cycles of 30 sec at 98°C, 20 sec at 65°C, 30 sec at 72°C, with a final extension of 5 min
at 72°C.
Genome assembly
For strains that have been sequenced previously, a comparative assembly approach was em-
ployed. Reads were assembled against the reference genome (S1 Table) with AMOScmp [14].
Assembled contigs were then aligned against the reference genome with ABACAS [15] to ob-
tain a genomic scaffold. Gaps in scaffolds were filled with IMAGE [16], which also splits un-
filled scaffolds into contigs. In addition to the comparative assembly, reads were also assembled
with Abyss v. 1.3.4 [17]. The two assemblies were aligned with Mugsy [18] and regions specific
to the de novo assembly were parsed from the MAF file [19], as has been done previously [20].
Putative unique regions in the de novo assembly were aligned against the comparative assembly
with BLASTN [21]. Regions that significantly aligned (>90% ID,>90% query length) to the
comparative assembly were filtered from the analysis. Remaining regions were combined with
the comparative assembly. Assembly errors were corrected from this concatenated assembly
with iCORN [22], using ten iterations. For strains that had not been sequenced previously, ge-
nomes were assembled de novo with Abyss v 1.3.4 and assembly errors were corrected with
iCORN. Assembly details are shown in S1 Table.
In silicomulti-locus sequence typing (isMLST)
BLASTN [21] was used to extract sequences from the seven loci in the B. pseudomalleiMLST
scheme [23] from all genome assemblies. To be considered a match, the alignment from the
query genome must match a reference allele 100%. Sequence types were assigned to genomes
when exact profile matches were identified. The isMLST functionality was performed with a
custom Python script (https://gist.github.com/jasonsahl/33b0d9a8e3ac035bb92c). MLST typ-
ing information is shown in S1 Table.
Single nucleotide polymorphism (SNP) and indel identification and
annotation
For re-sequencing efforts (Table 1), raw reads were mapped to the finished genome with
BWA-MEM v0.7.5 [24]. SNPs and indels were then called with the UnifiedGenotyper in
GATK v. 2.7 [25]; nucmer [26] was used to find duplicate regions in the reference genome and
any SNPs falling within duplicate regions were filtered from the analysis. For a SNP or indel to
be called, we required a minimum coverage of 6x and a minimum proportion threshold of
0.90. Nucleotide variants were annotated with snpEFF [27]. All variants were visually con-
firmed from BAM files with Tablet [28].
Synteny between previously sequenced genomes
In addition to identifying variants between finished genomes and re-sequencing projects, ge-
nome assemblies were aligned to completed genomes with MUMmer [29] and dot plots were
visualized with mummerplot to identify any structural variation.
Core genome SNP phylogeny
To visualize the phylogenetic diversity of genomes sequenced in this study, a core genome phy-
logenetic approach was employed; core regions are defined as sequence conserved in all exam-
ined genomes. A diverse set of finished and draft genomes was compiled (S2 Table). Raw reads
were mapped to B. pseudomallei K96243 [30] with BWA-MEM [24]. SNPs were called from
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each BAM file with GATK, using the EMIT_ALL_CONFIDENT_SITES method, with a mini-
mum coverage of 6x and a minimum proportion of 0.90. For genomic assemblies, SNPs were
identified from nucmer alignments. Positions in K96243 were directly mapped to the corre-
sponding position in each query genome assembly. A matrix was generated (S1 Dataset) with
NASP (http://tgennorth.github.io/NASP/) from all reference positions called and polymorphic
sites were identified. SNPs that could not be called by GATK, or failed to pass the depth or pro-
portion filters, were filtered from the matrix, as well as SNPs that fell within identified duplica-
tions. The remaining dataset consisted of 62,663 SNPs, 50,290 of them being informative. A
maximum likelihood phylogeny was inferred on this dataset with RAxML v8.0.17 [31, 32]
using the ASC_GTRGAMMAmodel and 100 bootstrap replicates. The retention index (RI)
value [33] was calculated with Phangorn [34].
SNP and homoplasy density
To identify the conservation of the reference chromosomes, as well as to potentially identify
any lateral gene transfer events that may confound the phylogeny, a SNP density (SD) and ho-
moplasy density (HD) approach was employed. The SNP matrix was parsed over 1-kb non-
overlapping windows of each chromosome and the number of informative SNPs was then cal-
culated. The dataset was then processed with Paup v4.0b10 [35] to calculate the retention
index (RI) value for each SNP. An RI value< 0.5 was considered to be homoplasious and the
number of homoplasious SNPs over the same 1-kb window was then calculated. The HD value
for each 1-kb window was calculated by dividing the number of homoplasious SNPs by the
total number of informative SNPs. The distribution of SD and HD across the two chromo-
somes in K96243 was visualized with Circos [36].
In silico gene screen
A set of previously described virulence factors [1, 30, 37–42] characterized in B. pseudomallei
were compiled (S3 Table). Genes were screened against the genomes sequenced in this study
with a large-scale blast score ratio (LS-BSR) approach [43]. Genes were translated with BioPy-
thon (www.biopython.org) and aligned against its nucleotide sequence with TBLASTN in
order to obtain the maximum alignment (reference) bit score. Each gene was then aligned
against each genome with TBLASTN in order to obtain the query alignment bit score. The BSR
[44] was obtained by dividing the reference bit score by the query bit score. Genes with a BSR
value> 0.90 or< 0.80 in all genomes were removed from the analysis; the complete LS-BSR
matrix is available as S2 Dataset. The genes were then correlated with the tree to identify phylo-
genetic patterns of gene presence/absence.
Genotype and phenotype correlations
Two approaches were performed to determine if there were correlations between genomic in-
formation and survival information obtained from animal challenge studies. The survival data
were split into three categories: low virulence (100% mouse survival after 21 days), intermedi-
ate virulence (<100%,>0% survival after 21 days), and high virulence (0% mouse survival
after 21 days). LS-BSR values across all genomes were multiplied by 100 in order to convert all
float values to integers. The adjusted LS-BSR values were then correlated with the categorical
virulence data using a Kruskal-Wallis test [45] implemented in QIIME v. 1.8.0 [46]. Core ge-
nome SNP data were also correlated to categorical data with a chi-square test implemented in
SciPy. P-values were corrected with the Benjamini-Hochberg correction [47]. To test for false
positives, genomes were randomly assigned to two groups of equal size and the average number
of SNPs unique to each group was calculated over 10 iterations.
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Unique genomic regions
In addition to screening characterized virulence genes in assembled genomes, a de novo ap-
proach was also performed. All coding regions (CDSs) from all genomes in the phylogeny were
compared with LS-BSR. Regions were determined to be unique to a given genome if they con-
tained a BSR< 0.4 in all non-targeted genomes. Each unique CDS was then aligned against the
GenBank [48] nucleotide database with BLASTN, and the closest hit, based on highest bit
score, was identified.
Ethics Statement
The animal protocol (2934–100007643) was approved by the Battelle Institutional Animal
Care and Use Committee. The research was conducted in compliance with the Animal Welfare
Act and followed the principles in the Guide for the Care and Use of Laboratory Animals from
the National Research Council, Office of Laboratory Animal Welfare (OLAW), and USDA.
Additionally, the research was conducted following an Institutional Animal Care and Use
Committee (IACUC) approved protocol. The institution where the research was conducted is
fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal
Care International (AAALAC).
Results
Comparisons of re-sequenced isolates with finished genomes
Five of the genomes sequenced in this study represent re-sequencing projects of finished ge-
nomes available in public databases (S1 Table). However, due to standard laboratory passages,
new nucleotide variants can accumulate [49], and were identified in the current study using
raw read data. The results demonstrate that many re-sequenced isolates show little mutation
since the genomes were published (Table 2). However, the version of K96243 that was se-
quenced in the current study showed numerous variant positions (33) compared to the com-
pleted genome (Table 2), including the loss of two annotated stop codons. Some of these
differences could be errors in the original genome sequence, which we are unable to verify. In
addition to the analysis of nucleotide variants, the synteny of genomes was visualized as dot
plots (S1 Fig) and demonstrated high synteny between all re-sequenced genome assemblies
and finished genomes.
Core genome single nucleotide polymorphism (SNP) phylogeny
To phylogenetically characterize the isolates sequenced in this study, a maximum likelihood
phylogeny was inferred from ~63,000 core genome SNPs (Fig. 1) identified from 44 genomes.
The results demonstrate that the isolates sequenced in the current study show a broad phyloge-
netic history compared to previously sequenced isolates. By including phylogenetically diverse
isolates in the isolate panel, local patterns of gene distribution do not bias the analysis. The re-
tention index (RI) value of the data and maximum likelihood phylogeny demonstrated signs of
homoplasy (RI = 0.62). Recombination in B. pseudomallei has been previously described [23]
and homoplasy was anticipated due the recombinatorial nature of the species.
SNP and homoplasy density
The RI value of the phylogeny demonstrated the presence of homoplasy. Based on this dataset,
the presence of homoplasy across the reference genome, K96243, was investigated with a SNP
and homoplasy density approach. The results demonstrate that with the isolates tested, chro-
mosome 1 of B. pseudomallei K96243 is more highly conserved than chromosome 2 (Fig. 2).
Comparative Genomics of B. pseudomallei Animal Rule Isolates
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Table 2. Nucleotide variant information for re-sequencing projects conducted in current study.
Name Chromosome Coordinate Reference Query Locus Effect Annotation Proportion Depth
K96243 NC006350.1 549058 G A BPSL0500 non-synonymous hexosaminidase 0.99 165
K96243 NC006350.1 549059 T G BPSL0500 synonymous hexosaminidase 1.00 163
K96243 NC006350.1 549061 C T BPSL0500 non-synonymous hexosaminidase 1.00 162
K96243 NC006350.1 549062 C T BPSL0500 synonymous hexosaminidase 1.00 165
K96243 NC006350.1 2399742 C G BPSL2010 non-synonymous lipid metabolism-like
protein
0.99 138
K96243 NC006350.1 2399743 C G BPSL2010 non-synonymous lipid metabolism-like
protein
0.99 140
K96243 NC006351.1 1607761 T C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
1.00 8
K96243 NC006351.1 1607796 G C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.98 100
K96243 NC006351.1 1607820 G C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.99 99
K96243 NC006351.1 1607822 G C BPSS1194 synonymous peptide synthase/
polyketide synthase
0.99 99
K96243 NC006351.1 1607825 G C BPSS1194 synonymous peptide synthase/
polyketide synthase
0.97 102
K96243 NC006351.1 1607838 T G BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.99 117
K96243 NC006351.1 1607851 T C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.99 111
K96243 NC006351.1 1607874 G T BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.97 62
K96243 NC006351.1 1607887 G C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
1.00 58
K96243 NC006351.1 1607894 G A BPSS1194 synonymous peptide synthase/
polyketide synthase
0.99 72
K96243 NC006351.1 1607902 G C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
1.00 68
K96243 NC006351.1 1607910 C A BPSS1194 non-synonymous peptide synthase/
polyketide synthase
0.95 57
K96243 NC006351.1 1607917 G C BPSS1194 non-synonymous peptide synthase/
polyketide synthase
1.00 48
K96243 NC006351.1 1607997 C A intergenic N/A N/A 0.96 49
K96243 NC006351.1 1608005 T C BPSS1195 stop codon
destroyed
non-ribosomal peptide
synthase
1.00 53
K96243 NC006351.1 1608012 G C BPSS1195 non-synonymous non-ribosomal peptide
synthase
0.98 55
K96243 NC006351.1 1608015 G T BPSS1195 non-synonymous non-ribosomal peptide
synthase
1.00 55
K96243 NC006351.1 1608017 T A BPSS1195 non-synonymous non-ribosomal peptide
synthase
1.00 55
K96243 NC006351.1 1608029 G C BPSS1195 synonymous non-ribosomal peptide
synthase
1.00 98
K96243 NC006351.1 1615675 C T BPSS1197 non-synonymous BPSS1197 0.98 192
K96243 NC006351.1 1764438 G T intergenic N/A N/A 1.00 96
K96243 NC006351.1 1764448 G T intergenic N/A N/A 0.93 101
K96243 NC006351.1 2337386 A C BPSS1703 stop codon
destroyed
hypothetical protein 1.00 188
1106a NC_009076.1 797819 T G BURPS1106A_0812 non-synonymous sensor histidine
kinase
0.99 125
(Continued)
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Additionally, the homoplasy is distributed across both chromosomes, with no clear regions as-
sociated with specific recombination or lateral gene transfer events.
Unique coding sequences (CDSs)
B. pseudomallei has a highly plastic genome and has the ability to acquire new genes horizon-
tally from other microorganisms, especially as the pathogen persists in the environment. A
large-scale blast score ratio (LS-BSR) analysis was performed on the 44 B. pseudomallei ge-
nomes in the phylogeny (Fig. 1) to identify any unique CDSs in the 11 isolates sequenced in the
current study; the criteria for a CDS to be considered unique is that it must have a BSR
value< 0.4 in all non-targeted genomes. A list of closest BLAST hits to unique CDSs not asso-
ciated with either B. pseudomallei or B.mallei, based on the highest bit score, is shown in
Table 3. These regions are likely associated with genomic islands horizontally transferred from
related organisms [50].
Virulence gene profile
A comprehensive set of virulence-associated genes (S3 Table) was screened against the 11 ge-
nomes sequenced in this study with LS-BSR. To only compare differentially conserved regions,
genes were filtered if they had a BSR value> 0.90 in all 11 genomes. The resulting variable set
of genes (n = 54) was correlated to the phylogeny and LS-BSR values were visualized as a heat-
map (Fig. 3). The results demonstrate that phylogenetically-distinct isolates contain a variable
composition of virulence-associated genes.
Every B. pseudomallei isolate in this study contained the B. pseudomallei bimA (BimABp) al-
lele [51], except B. pseudomalleiMSHR668, which contained the alternative B.mallei-type
(BimABm). The most severe clinical presentations have been associated with the co-occurrence
of BimABm with another virulence-associated gene, filamentous hemagglutinin fhaB3
(BPSS2053 in B. pseudomallei K96243), which is linked with adhesion and heightened viru-
lence [52, 53]. While B. pseudomalleiMSHR668 is missing fhaB3, it does contain another fhaB
gene (similar to fhaB1 from B. pseudomalleiMSHR305 [54]). fhaB3 was observed in all Asian
isolates in this study, which is consistent with previous work [54, 55]. Isolates sequenced in this
study either contained the Yersinia-like fimbriae cluster (YLF) or the B. thailandensis-like fla-
gellum and chemotaxis (BTFC) gene cluster. These genes were included in our analysis because
they are suggested as being active during melioidosis.
Two isolates in this study, 1026b and MSHR305, exhibited reduced sequence homology to
the T6SS-1 gene, BPSS1511. The T6SS-1 representative sequence, icmF gene (BPSS1511),
which is required for intracellular growth of many pathogens associated with eukaryotic cells
[56], showed homology, but lower sequence identity, in 1026b and MSHR305. Four isolates
Table 2. (Continued)
Name Chromosome Coordinate Reference Query Locus Effect Annotation Proportion Depth
1026b NC_017832.1 2020919 G A BP1026B_II1596 non-synonymous type VI secretion
system, VGR
0.91 297
668 NC_009074.1 3755785 G C BURPS668_3852 synonymous chemotaxis protein
methyltransferase
0.99 289
668 NC_009075.1 92668 CG C intergenic N/A N/A 0.91 276
doi:10.1371/journal.pone.0121052.t002
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Fig 1. A maximum likelihood phylogeny inferred from a concatenation of ~63,000 core-genome single
nucleotide polymorphisms (SNPs) identified in the eleven genomes sequenced in this study, shown
in red, and a reference set of genomes (S2 Table). The tree was inferred with RAxML v8 [31, 32] using the
ASC_GTRGAMMAmodel and 100 bootstrap replicates. Filled circles are placed at nodes where the
bootstrap support values are>90%.
doi:10.1371/journal.pone.0121052.g001
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(MSHR5855, MSHR305, 1106a, and HBPUB10134a) exhibited reduced sequence homology
for BPSS1493, a hypothetical protein associated with type VI secretion.
Animal challenge studies
To identify differential virulence between ten of the eleven isolates sequenced in this study,
BALB/c mice (seven per group) were challenged at different concentrations of inoculum
(Table 4). At an average of ~10 colony forming units (CFUs) per group, four of the ten isolates
killed all of the mice in the group, 5 of the isolates killed an intermediate number of mice, and
one isolate (1106a) killed none of the mice (Table 4, S2 Fig, S4 Table); HBPUB10303a was
treated as intermediate in terms of virulence, despite the fact that the isolate was challenged for
only 14 days instead of 21 in this experiment. At a high concentration of inoculum (~12,000
CFUs), none of the mice survived when challenged with any of the ten panel isolates. This
demonstrates that all of the isolates are virulent by intranasal inoculation, but there is a dose-
dependent virulence response.
Genotype and phenotype correlations
Differences were observed in both the virulence gene profile and the animal challenge studies.
To identify if any CDSs were associated with differential virulence, a combined LS-BSR/QIIME
analysis was performed. A Kruskal-Wallis test [45] demonstrated that numerous CDSs were
significantly (false detection rate adjusted (FDR) p<0.05) differentially conserved between
groups (Table 5); three of these CDSs (BPSS0771, BPSS1185, BPSS1269) have previously been
associated with virulence (Table 5). Additionally, an association was made between core ge-
nome SNPs and differential virulence. Forty SNPs were only identified in high virulence iso-
lates (Table 6), which could be due to descent and subsequent loss by intermediate and low
Fig 2. Plots of single nucleotide polymorphism (SNP) density and homoplasy density (HD), across the two chromosomes of the reference isolate,
K96243 [30]. The outer ring represents the number of informative SNPs across 1-kb genomic intervals. The inner ring indicates the number of homoplasious
SNPs, as determined by a retention index (RI) value<0.5 calculated by Paup [35], divided by the total number of informative SNPs over the same 1-kb
genomic interval. HD and SD values were visualized with Circos [36].
doi:10.1371/journal.pone.0121052.g002
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virulence isolates, but may also be associated with convergent evolution and virulence (Fig. 3).
By randomly assigning genomes to high and low virulence groups, an average of 31 correlated
SNPs were identified over ten iterations. This demonstrates that with small sample sets, identi-
fied correlations would definitely need to be corroborated with functional characterization.
Discussion
Burkholderia pseudomallei is an important pathogen as both the causative agent of melioidosis
and as a potential biothreat agent. In the development of medical countermeasures against
melioidosis, a panel of clinically relevant isolates have been identified [7] for challenge studies
under the FDA Animal Rule [8]. In this study, we sequenced all 6 of these isolates as well as 5
additional isolates associated with human inhalational melioidosis. A comparative genomics
approach was employed to understand the genetic composition of each genome and the distri-
bution of genetic elements between genomes. These results were correlated with animal surviv-
al data to determine if phenotype/genotype correlations could be identified.
Ten of the 11 isolates were passed through a BALB/c mouse model in groups of seven mice
per isolate. Differential virulence was observed between isolates, with MSHR668 demonstrating
the highest virulence (S2 Fig, Table 2), based on time to death. An attempt was made to corre-
late both the distribution of coding sequences (CDSs), based on large-scale blast score ratio
(LS-BSR) values, and single nucleotide polymorphisms (SNPs), with differential virulence.
Table 3. Annotation for unique genes identified in genomes sequenced in the current study.
Genome closest BLAST
match
closest BLAST annotation nearest BLAST organism protein ID
(%)
query
length
MSHR5858 BUPH_05469 integrase catalytic subunit Burkholderia phenoliruptrix 99 99
NCTC13392 BDB_110343 hypothetical blood disease bacterium R229 83 99
NCTC13392 BDB_110341 hypothetical blood disease bacterium R229 82 98
10134a YP_582472 tyrosine-based site-speciﬁc
recombinase
Cupriavidus metallidurans CH34 64 98
10134a YP_005995055 hypothetical Ralstonia solanacearum CMR15 62 98
10134a YP_005995053 putative integrase Ralstonia solanacearum CMR15 49 98
10134a WP_017232947 hypothetical Pandoraea sp. B-6] 91 99
10134a WP_017232948 DEAD/DEAH box helicase Pandoraea sp. B-6] 91 100
10134a WP_008918033 N-6 DNA methylase Burkholderia sp. H160 78 99
10134a WP_017232950 ATP-dependent helicase Pandoraea sp. B-6] 87 99
10134a WP_006395564 hypothetical Achromobacter xylosoxidans 60 83
HBPUB10303a YP_443256 type I restriction-modiﬁcation system Burkholderia thailandensis E264 78 72
HBPUB10303a YP_443255 hypothetical Burkholderia thailandensis E264 91 99
HBPUB10303a YP_005028223 hypothetical Dechlorosoma suillum PS 74 99
HBPUB10303a WP_008248767 hypothetical Limnobacter sp. MED105 51 99
HBPUB10303a YP_006030638 helicase domain-containing protein Ralstonia solanacearum Po82 79 99
MSHR5855 Bamb_2400 phage integrase family protein Burkholderia ambifaria AMMD 89 96
MSHR5855 BTQ_1983 putative membrane proten Burkholderia thailandensis
2002721723
99 100
MSHR5855 BTJ_373 hypothetical Burkholderia thailandensis E444 99 100
MSHR5855 bglu_1g24070 hypothetical Burkholderia glumae BGR1 91 99
MSHR5855 BTI_1944 hypothetical Burkholderia thailandensis MSMB121 99 100
MSHR5855 BTI_1943 hypothetical Burkholderia thailandensis MSMB121 78 100
MSHR5855 BTI_1942 helix-turn-helix family protein Burkholderia thailandensis MSMB121 99 100
MSHR5855 Rpic12D_1056 lipoprotein releasing system Ralstonia pickettii 12D 98 100
doi:10.1371/journal.pone.0121052.t003
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Three CDSs previously associated with virulence were differentially conserved between disease
severity groups (Table 4). Additionally, SNPs were identified that were only present in high-
virulence isolates (Table 6). While the limited number of isolates tested in this study precludes
definitive correlations between genotype and phenotype, differentially conserved CDSs and/or
SNPs may inform larger-scale targeted functional studies, which may help to better understand
the pathogenesis of B. pseudomallei, and subsequently, may improve human health.
A maximum likelihood phylogeny inferred from a concatenation of ~60,000 core-genome
SNPs demonstrated that the eleven isolates sequenced in the current study represent broad
phylogenetic diversity. The retention index (RI) value, which provides a representation of the
homoplasy in the dataset, demonstrated signs of homoplasy, which can confound accurate
phylogenetic reconstruction. Plotting the observed homoplasy density (HD) across both
Fig 3. A heatmap of blast score ratio (BSR) values [44] calculated from a known set of virulence factors characterized in B. pseudomallei (S3
Table) with the large-scale blast score ratio (LS-BSR) pipeline [43]. Amaximum likelihood phylogeny was inferred on a concatenation of single
nucleotide polymorphisms (SNPs) and was correlated to the heatmap.
doi:10.1371/journal.pone.0121052.g003
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chromosomes of B. pseudomallei K96243 demonstrated that the homoplasy was evenly distrib-
uted, with no isolated regions of recombination in the core genome. Although this underlying
homoplasy may confound phylogenetic relationships, especially in deeply branching nodes,
the phylogeny still demonstrates the overall diversity of the eleven isolates sequenced in the
current study.
Differences in the distribution of virulence-associated genes were observed based a LS-BSR
analysis. One clear difference was the presence of the B.mallei bimA (BimABm) allele in
MSHR668 and the B. pseudomallei version (BimABp) in all other isolates (Fig. 3). In previous
studies, 12% of Australian isolates contained BimABm [55, 57], although both versions appear
to perform actin-based motility effectively. An association between neurological melioidosis
and strains with BimABm was recently reported [55]. Severe clinical presentations have been as-
sociated with the co-occurrence of BimABm and the hemagglutinin, fhaB3. The lack of fhaB3 in
isolates exhibiting BimABm was correlated with cutaneous melioidosis without sepsis [55].
Testing isolates with varied distributions of these virulence components will help corroborate
these associations.
The Inv/Mxi-Spa-like type III secretion system (T3SS-3) [58] is essential for the survival of
B. pseudomallei in the host [59, 60] and closely resembles secretion systems found in other ani-
mal pathogens (Salmonella spp. and Shigella spp.). B. pseudomallei isolates 1026b and
Table 4. Survival data of 10 strains injected intranasally in BALB/c mice.
Challenge Strain Target CFU:10 Target CFU: 100 Target CFU: 1000 Target CFU: 10000
CFUs %survival CFUs %survival CFUs %survival CFUs %survival
K96243 13(+/-0) 57 170(+/-21) 14 1581(+/-212) 0 11940(+/-1485) 0
MSHR406e 13(+/-0) 0 135(+/-4) 0 1365(+/-106) 0 12840(+/-636) 0
1026b 12(+/-0) 57 127(+/-11) 0 1215(+/-106) 0 11355(+/-785) 0
1106a 12(+/-0) 100 128(+/-23) 71 1220(+/-112) 29 12090(+/-2121) 0
MSHR305 16(+/-1) 29 149(+/-15) 0 1524(+/-21) 0 14100(+/-2121) 0
MSHR668 14(+/-0) 0 122(+/-2) 0 1095(+/-8) 0 12945(+/-912) 0
MSHR5855 16(+/-1) 0 185(+/-48) 0 1575(+/-136) 0 14550(+/-933) 0
MSHR5858 14(+/-2) 86 154(+/-8) 14 1485(+/-119) 0 15750(+/-2630) 0
HBPUB10303a 6(+/-0) 71 59(+/-1) 14 537(+/-38) 0 5280(+/-424) 0
HBPUB10134a 16 0 163 0 1779 0 18810 0
doi:10.1371/journal.pone.0121052.t004
Table 5. Correlations of LS-BSR values with observed differential virulence in BALB/c mice.
Accession Annotation BSR average (high)* BSR average (intermediate)* BSR average (low)* FDR p-value
BPSS1185 undeﬁned product 73.5 87.2 14 0.0000
BPSL2990 histone H1-like protein 100 71 41 0.0003
BPSL0016 general secretory pathway protein L 100 99.8 51 0.0022
BDL_4286 response regulator 97.25 87.2 49 0.0082
BPSS1308 isoaspartyl peptidase 100 99.6 54 0.0082
BPSL0859 N-acetylmuramoyl-L-alanine amidase 100 100 55 0.0106
BPSS0771 hypothetical protein 98 81.6 50 0.0147
BPSS1269 peptide_synthase/polyketide_synthase 87.75 99.2 54 0.0324
BPSS1212 hypothetical protein 99.75 78.4 54 0.0454
*High, intermediate and low virulence determined by intranasal challenge at ~10 colony forming units.
doi:10.1371/journal.pone.0121052.t005
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HBPUB10134a appear to have reduced homology for BPSS1528, which is described as a (HNS-
like regulatory) hypothetical protein in the T3SS-3 system. Several proteins act together to
form a pore that becomes bound to the host membrane, thus facilitating the delivery of effector
proteins [61, 62]. This system is also likely involved in defenses against autophagy by transport-
ing the BopA effector [63, 64]. In this study, we observed sequence homology variation among
many of the isolates in the gene, BPSS1629, from the T3SS-2 cluster.
Table 6. Single nucleotide polymorphisms (SNPs) unique to high virulence isolates.
Chrom Coordinate K96243 call query call refAA derivedAA locus tag Annotation
NC_006350.1 220073 C T R Q BPSL0211 lipid A biosynthesis lauroyl acyltransferase
NC_006350.1 220163 C T R Q BPSL0211 lipid A biosynthesis lauroyl acyltransferase
NC_006350.1 240744 T C M V BPSL0230 ﬂiF; ﬂagellar MS-ring protein
NC_006350.1 534205 G T A D BPSL0492 hypothetical protein
NC_006350.1 554241 T C A A BPSL0504 rpoH; RNA polymerase factor sigma-32
NC_006350.1 1839157 C G N/A N/A intergenic N/A
NC_006350.1 1839166 G A N/A N/A intergenic N/A
NC_006350.1 1839172 T C N/A N/A intergenic N/A
NC_006350.1 1839197 A C N/A N/A intergenic N/A
NC_006350.1 1839256 A G N/A N/A intergenic N/A
NC_006350.1 1839334 C T N/A N/A intergenic N/A
NC_006350.1 1839988 T C K R BPSL1583 hypothetical protein
NC_006350.1 1840050 G A A A BPSL1583 hypothetical protein
NC_006350.1 2402720 T C N/A N/A intergenic N/A
NC_006350.1 2440328 A G D D BPSL2041 hypothetical protein
NC_006350.1 2553415 C G A A BPSL2126 transport-related, membrane protein
NC_006350.1 2555149 G A N/A N/A intergenic N/A
NC_006350.1 2555151 C T N/A N/A intergenic N/A
NC_006350.1 2820597 A G I T BPSL2334 hypothetical protein
NC_006350.1 2847891 T C N/A N/A intergenic N/A
NC_006350.1 3021077 A C N/A N/A intergenic N/A
NC_006350.1 3403668 G T T T BPSL2842 FAD-binding oxidase
NC_006350.1 3654489 C G N/A N/A intergenic N/A
NC_006350.1 3924581 G A H H BPSL3305 cheW; chemotaxis protein
NC_006350.1 4073158 T C E G BPSL3430 glutamine amidotransferase
NC_006351.1 702758 G A G S BPSS0515 hypothetical protein
NC_006351.1 1236140 T G P P BPSS0936 hypothetical protein
NC_006351.1 1269935 T C N/A N/A intergenic N/A
NC_006351.1 1398575 C T P P BPSS1026 hypothetical protein
NC_006351.1 1398581 A G * W BPSS1026 hypothetical protein
NC_006351.1 1917766 T C N/A N/A intergenic N/A
NC_006351.1 2455301 T G S A BPSS1795 hypothetical protein
NC_006351.1 2514965 G A N/A N/A intergenic N/A
NC_006351.1 2695450 C T N/A N/A intergenic N/A
NC_006351.1 3000485 G A N/A N/A intergenic N/A
NC_006351.1 3042744 A G D D BPSS2265 monooxygenase
NC_006351.1 3097464 G A N/A N/A intergenic N/A
NC_006351.1 3097471 C T N/A N/A intergenic N/A
NC_006351.1 3097776 C A N/A N/A intergenic N/A
NC_006351.1 3160929 G A N/A N/A intergenic N/A
doi:10.1371/journal.pone.0121052.t006
Comparative Genomics of B. pseudomallei Animal Rule Isolates
PLOS ONE | DOI:10.1371/journal.pone.0121052 March 24, 2015 14 / 18
One of the most dramatic differences observed between isolates was from representative
genes in the Yersinia-like fimbriae (YLF) gene cluster and the BTFC gene cluster. This division
is mutually exclusive [54, 55] and it is unclear whether one cluster confers enhanced virulence
over the other and no correlations have been identified between gene cluster and disease severi-
ty [55]. While YLF genes are generally associated with isolates from Thailand [55], we found
no geographical correlation in the small sample set that we analyzed in the current study
(Fig. 3).
The FDA Animal Rule was set up to identify a set of relevant isolates that could be used in
lieu of human clinical trials in the development of effective medical countermeasures against
human disease, including melioidosis. The data presented in this study will provide a genomic
background to better understand virulence in B. pseudomallei and may also help in the devel-
opment of more effective medical countermeasures.
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